Stocks
Intellia Therapeutics (NTLA) P/S US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/S | ? | 16.1 | 52.5 | 253.6 | 51.5 | 74.6 | 44.8 | ||
| Changes by years, y/y, % | -17% | +227% | +383% | -80% | +45% | +31.0% | |||
Intellia Therapeutics. P/S
Intellia Therapeutics. P/S, changes, %
Intellia Therapeutics (NTLA) P/S US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| P/S | ? | 61.2 | 67.8 | 54.1 | 76.0 | 49.9 | 44.8 | |
| Changes by years, y/y, % | -57% | -22% | -35% | +40% | -18% | |||
| Changes by quarters, q/q, % | +13% | +11% | -20% | +40% | -34% | |||
